Syncom Formulations (India) Limited

Web: syncomformulations.com NSE: SYNCOMF BSE: 524470 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

13 0(0%)

Volume

18L as on 23, Jun

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

66/100

Growth Score

90/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,234

No. of Shares

P/E

60.04

P/B

6.65

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

11.08

ROCE

Profit Growth

Listing Date

18-Nov-22

Promoter Holding

50.57%

FII Holding

0.21%

DII Holding

Price Chart

Price Performance

1 Week3%

1 Month3%

3 Months24%

6 Months13%

1 Year13%

YTD13%

Moving Average

5 Day SMA14

10 Day SMA14

20 Day SMA14

30 Day SMA14

50 Day SMA14

61 Day SMA14

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	14	14	14	14
Resistance 2	14	14	14	14
Resistance 1	14	14	14	14
Pivot Point	14	14	14	14
Support 1	14	14	14	14
Support 2	14	14	14	14
Support 3	14	14	14	14

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(0.01) 50.57%	(4.51) 50.57%	(2.11) 46.12%	(0.01) 44.01%	(0.01) 44.01%
FIIs	(-0.11) 0.21%	(0.21) 0.26%	(-0.31) 0.10%	(0.31) 0.41%	(0.01) 0.11%	(0.01) 0.13%	(0.01) 0.10%	(0.01) 0.09%	(0.11) 0.08%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(-0.61) 0.00%	(0.01) 0.58%
Public	49.23%	49.17%	49.33%	49.02%	49.32%	49.30%	49.34%	49.34%	49.35%	49.44%	49.44%	49.44%	49.44%	49.43%	49.43%	49.43%	53.88%	55.99%	55.40%
No. of Shareholders	431,690	442,280	457,364	471,066	484,529	489,520	469,242	376,530	325,761	289,982	224,252	224,925	227,478	232,069	232,750	235,517	232,617	188,981	120,800

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Mar 2014
Sales	135	115	122	117	149	128	102	87	75	65	64	60	61	57	54	51	58	57	53	42.75
Sales Growth % (YoY)	-9%	-9.7%	19%	34%	99.6%	95.8%	60.3%	45.8%	22.3%	13.5%	17.2%	16.4%	4.7%	0.3%	2.9%	-	-	-	-	22.8%
Sales Growth % (QoQ)	17.4%	-5.7%	4.3%	-21.5%	16.4%	25.5%	17.2%	16%	15.4%	1.6%	6.7%	-1.6%	7%	5.6%	5.9%	-12.1%	1.8%	7.5%	24%	-
Expenses	113	94	103	101	131	113	90	77	65	58	57	53	55	51	50	48	56	52	47	38
Operating Profit	22	21	18	16	18	15	12	10	9	7	6	6	6	6	4	3	2	5	6	4.75
OPM %	16	18	15	14	12	12	12	12	13	11	10	11	10	10	8	7	4	9	11	11.11
Other Income	15	6	5	6	7	4	4	1	3	5	4	2	7	2	3	3	6	2	3	0.54
Interest	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	0	1	0	0	0.06
Depreciation	2	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0.77
Profit before tax	34	25	22	20	23	17	15	10	10	9	8	6	10	6	5	5	6	6	7	4.46
Tax %	25	25	25	22	24	25	25	24	26	25	23	28	18	30	33	22	16	33	23	41.26
Net Profit	25	19	17	16	18	13	11	8	7	7	7	4	8	4	4	4	5	4	6	2.62
Net Profit Growth % (QoQ)	31.6%	11.8%	6.2%	-11.1%	38.5%	18.2%	37.5%	14.3%	-	-	75%	-50%	100%	-	-	-20%	25%	-33.3%	129%	-
Net Profit Growth % (YoY)	38.9%	46.2%	54.5%	100%	157.1%	85.7%	57.1%	100%	-12.5%	75%	75%	-	60%	-	-33.3%	-	-	-	-	-
TTM Net Profit	77	70	64	58	50	39	33	29	25	26	23	20	20	17	17	19	15	10	6	0
EPS in Rs	0.27	0.2	0.18	0.17	0.19	0.14	0.12	0.08	0.08	0.07	0.07	0.05	0.09	0.04	0.04	0.04	0.06	0.05	0.07	0.03

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	489	463	262	222	216	185	184	173	151	115
Sales Growth %	5.7%	76.6%	18.3%	2.6%	-	0.5%	6.1%	14.6%	31.6%	-
Expenses	412	408	232	202	196	168	167	155	135	104
Operating Profit	77	54	30	20	20	17	17	18	16	11
OPM %	16	12	11	9	9	9	9	11	11	9
Other Income	31	17	14	15	12	3	3	1	1	1
Interest	1	1	5	3	2	0	0	0	0	1
Depreciation	7	5	5	5	4	3	3	3	3	3
Profit before tax	101	66	34	27	26	16	16	16	14	8
Tax %	24	25	25	24	24	34	36	38	33	33
Net Profit	76	49	25	20	20	11	10	10	9	6
Net Profit Growth %	55.1%	96%	25%	-	81.8%	10%	-	11.1%	50%	-
EPS in Rs	0.81	0.53	0.27	0.21	0.23	0.13	0.13	0.13	0.12	0.07
Dividend Payout %	0	0	0	0	13	15	15	16	17	24

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	58	23	-6	11	16	14	24	0	7	6
Cash from Investing Activity	-51	-18	83	-45	-27	-18	-23	1	-4	0
Cash from Financing Activity	-3	-68	-15	35	8	5	-2	1	-1	-6
Net Cash Flow	4	-63	62	1	-2	1	-1	2	2	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	94	94	94	94	94	94	86	78	78	78	78	22
Reserves	321	284	248	220	194	162	136	39	31	22	17	65
Borrowings	1	1	5	14	72	83	58	12	6	6	3	2
Other Liabilities	117	77	67	45	44	39	28	50	61	31	42	33
Total Liabilities	534	456	413	372	405	378	308	180	175	138	140	123
Fixed Assets	184	124	125	117	120	91	94	55	46	46	50	50
CWIP	0	8	0	1	0	26	6	0	5	0	0	0
Investments	109	148	93	86	66	64	43	36	23	6	9	7
Other Assets	241	176	196	168	219	197	165	89	101	85	80	66
Total Assets	534	456	413	372	405	378	308	180	175	138	140	123

Delivery

#	Date	13 26% 17	Value (Cr)	Q/T 629	Del 43	Del 5
1	22-Jul	13	2	321	59	1
2	21-Jul	14	1	391	62	1
3	20-Jul	14	1	398	50	1
4	17-Jul	13	2	437	54	1
5	16-Jul	14	2	387	55	1
6	15-Jul	14	2	396	51	1
7	14-Jul	14	2	393	58	1
8	13-Jul	14	2	415	57	1
9	10-Jul	14	3	451	54	2
10	9-Jul	14	2	526	51	1
11	8-Jul	14	2	407	54	1
12	7-Jul	14	2	408	44	1
13	6-Jul	14	2	386	59	1
14	3-Jul	14	2	433	52	1
15	2-Jul	14	3	560	50	2
16	1-Jul	14	2	461	50	1
17	30-Jun	14	4	684	45	2
18	29-Jun	14	5	641	31	2
19	25-Jun	14	2	510	61	1
20	24-Jun	14	2	461	54	1
21	23-Jun	14	3	582	50	1
22	22-Jun	14	2	519	66	1
23	19-Jun	14	2	529	50	1
24	18-Jun	14	3	413	58	2
25	17-Jun	14	3	435	62	2
26	16-Jun	14	2	438	54	1
27	15-Jun	14	3	512	54	1
28	12-Jun	14	2	559	57	1
29	11-Jun	14	3	605	32	1
30	10-Jun	14	2	420	63	1
31	9-Jun	15	3	541	51	1
32	8-Jun	14	2	444	47	1
33	5-Jun	14	2	470	55	1
34	4-Jun	15	4	757	49	2
35	3-Jun	15	3	581	47	1
36	2-Jun	15	4	639	49	2
37	1-Jun	15	4	558	36	1
38	29-May	15	5	540	53	2
39	27-May	16	6	570	39	2
40	26-May	16	8	616	38	3
41	25-May	16	43	936	21	9
42	22-May	14	2	562	65	1
43	21-May	14	2	449	47	1
44	20-May	14	3	629	45	1
45	19-May	14	2	472	51	1
46	18-May	14	3	426	54	1
47	15-May	14	2	483	55	1
48	14-May	14	2	436	48	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	1,234c	9c	0.68
22-Jul	1,243c	41c	3.22
21-Jul	1,284c	22c	1.71
17-Jul	1,262c	26c	2.04
16-Jul	1,289c	19c	1.44
15-Jul	1,308c	7c	0.51
14-Jul	1,301c	12c	0.93
13-Jul	1,313c	31c	2.31
10-Jul	1,344c	20c	1.49
09-Jul	1,325c	51c	3.99
08-Jul	1,274c	33c	2.52
07-Jul	1,307c	8c	0.57
06-Jul	1,314c	53c	3.85
02-Jul	1,367c	9c	0.69
01-Jul	1,357c	7c	0.49
30-Jun	1,351c	15c	1.13
29-Jun	1,336c	30c	2.30
26-Jun	1,306c	6c	0.43
25-Jun	1,311c	3c	0.22
24-Jun	1,309c	2c	0.14
23-Jun	1,307c	7c	0.50
22-Jun	1,313c	11c	0.85
19-Jun	1,325c	7c	0.50
18-Jun	1,318c	24c	1.82
17-Jun	1,342c	16c	1.18
16-Jun	1,358c	9c	0.69
15-Jun	1,368c	24c	1.75
12-Jun	1,344c	24c	1.85
11-Jun	1,320c	26c	1.96
10-Jun	1,346c	0	0

Stock Checklist

Price is below from 52 week high low average: 37%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 2 fund scheme(s) across 1 fund house(s) as of Jul26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.05%	-	0

Syncom Formulations (India) Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements